The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7795292 B1

PDF
Full Text
Expired
Date of Patent:
Sep. 14, 2010

Filed:

Sep. 20, 2005
Applicants:

Todd M. Heidelbaugh, Fountain Valley, CA (US);

Ken Chow, Newport Coast, CA (US);

Phong X. Nguyen, Placentia, CA (US);

Daniel W. Gil, Corona Del Mar, CA (US);

John E. Donello, Dana Point, CA (US);

Michael E. Garst, Newport Beach, CA (US);

Larry A. Wheeler, Irvine, CA (US);

John R. Cappiello, Irvine, CA (US);

Inventors:

Todd M. Heidelbaugh, Fountain Valley, CA (US);

Ken Chow, Newport Coast, CA (US);

Phong X. Nguyen, Placentia, CA (US);

Daniel W. Gil, Corona Del Mar, CA (US);

John E. Donello, Dana Point, CA (US);

Michael E. Garst, Newport Beach, CA (US);

Larry A. Wheeler, Irvine, CA (US);

John R. Cappiello, Irvine, CA (US);

Assignee:

Allergan, Inc., Irvine, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4164 (2006.01); C07D 233/84 (2006.01);
U.S. Cl.
CPC ...
Abstract

Compounds of Formula 1 where the variables have the meaning defined in the specification are used to activate alphaadrenergic receptors. The compounds of Formula 1 are incorporated in pharmaceutical compositions and are used as medicaments in mammals, including humans, for treatment of diseases and or alleviations of conditions which are responsive to treatment by agonists of alphaadrenergic receptors.


Find Patent Forward Citations

Quick Actions:

Heidelbaugh, Todd. (2010). Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same (U.S. Patent No. 7795292). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/7795292

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…